Europe Vaccine Adjuvants Market by Manufacturers, Countries, Type and Application, Forecast to 2022

June 2017 | 124 pages | ID: E78F5F2D3B1EN
GlobalInfoResearch

Abstracts

An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.

Scope of the Report:

This report focuses on the Vaccine Adjuvants in Europe market, especially in Germany, UK, France, Russia, and Italy. This report categorizes the market based on manufacturers, countries, type and application.

Market Segment by Manufacturers, this report covers

• SEPPIC
• SDA BIO
• Brenntag Biosector
• SPI Pharma
• MVP Laboratories
• Tj Kaiwei
• Novavax
• Zhuoyue
• Aphios
• GSK
• CSL Limited
• Brenntag Biosector
• SEPPIC
• SPI Pharma
• Novavax
• Avanti Polar Lipids
• Aphios

Market Segment by Countries, covering

• Germany
• UK
• France
• Russia
• Italy

Market Segment by Type, covers

• Oral
• Subcutaneous
• Intramuscular
• Others

Market Segment by Applications, can be divided into

• Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications)
• Human Vaccine Adjuvants (Research Applications, Commercial Applications)

There are 17 Chapters to deeply display the Europe Vaccine Adjuvants market.

Chapter 1, to describe Vaccine Adjuvants Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Vaccine Adjuvants, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers in Europe, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the Europe market by countries, covering Germany, UK, France, Italy and Russia, with sales, price, revenue and market share of Vaccine Adjuvants, for each country, from 2012 to 2017;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type and application, from 2012 to 2017;

Chapter 7, 8, 9, 10 and 11, to analyze the key countries by manufacturers, Type and Application, covering Germany, UK, France, Italy and Russia, with sales, revenue and market share by manufacturers, types and applications;

Chapter 12, Vaccine Adjuvants market forecast, by countries, type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022;

Chapter 13, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 14, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 15, to describe Vaccine Adjuvants sales channel, distributors, traders, dealers etc.

Chapter 16 and 17, to describe Vaccine Adjuvants Research Findings and Conclusion, Appendix, methodology and data source

Contents

1 MARKET OVERVIEW

1.1 Vaccine Adjuvants Introduction
1.2 Market Analysis by Type
  1.2.1 Oral
  1.2.2 Subcutaneous
  1.2.3 Intramuscular
  1.2.4 Others
1.3 Market Analysis by Applications
  1.3.1 Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications)
  1.3.2 Human Vaccine Adjuvants (Research Applications, Commercial Applications)
1.4 Market Analysis by Countries
  1.4.1 Germany Status and Prospect (2012-2022)
  1.4.2 France Status and Prospect (2012-2022)
  1.4.3 UK Status and Prospect (2012-2022)
  1.4.4 Russia Status and Prospect (2012-2022)
  1.4.5 Italy Status and Prospect (2012-2022)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 SEPPIC
  2.1.1 Profile
  2.1.2 Vaccine Adjuvants Type and Applications
    2.1.2.1 Type
    2.1.2.2 Type
  2.1.3 SEPPIC Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.1.4 Business Overview
  2.1.5 SEPPIC News
2.2 SDA BIO
  2.2.1 Profile
  2.2.2 Vaccine Adjuvants Type and Applications
    2.2.2.1 Type
    2.2.2.2 Type
  2.2.3 SDA BIO Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.2.4 Business Overview
  2.2.5 SDA BIO News
2.3 Brenntag Biosector
  2.3.1 Profile
  2.3.2 Vaccine Adjuvants Type and Applications
    2.3.2.1 Type
    2.3.2.2 Type
  2.3.3 Brenntag Biosector Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.3.4 Business Overview
  2.3.5 Brenntag Biosector News
2.4 SPI Pharma
  2.4.1 Profile
  2.4.2 Vaccine Adjuvants Type and Applications
    2.4.2.1 Type
    2.4.2.2 Type
  2.4.3 SPI Pharma Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.4.4 Business Overview
  2.4.5 SPI Pharma News
2.5 MVP Laboratories
  2.5.1 Profile
  2.5.2 Vaccine Adjuvants Type and Applications
    2.5.2.1 Type
    2.5.2.2 Type
  2.5.3 MVP Laboratories Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.5.4 Business Overview
  2.5.5 MVP Laboratories News
2.6 Tj Kaiwei
  2.6.1 Profile
  2.6.2 Vaccine Adjuvants Type and Applications
    2.6.2.1 Type
    2.6.2.2 Type
  2.6.3 Tj Kaiwei Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.6.4 Business Overview
  2.6.5 Tj Kaiwei News
2.7 Novavax
  2.7.1 Profile
  2.7.2 Vaccine Adjuvants Type and Applications
    2.7.2.1 Type
    2.7.2.2 Type
  2.7.3 Novavax Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.7.4 Business Overview
  2.7.5 Novavax News
2.8 Zhuoyue
  2.8.1 Profile
  2.8.2 Vaccine Adjuvants Type and Applications
    2.8.2.1 Type
    2.8.2.2 Type
  2.8.3 Zhuoyue Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.8.4 Business Overview
  2.8.5 Zhuoyue News
2.9 Aphios
  2.9.1 Profile
  2.9.2 Vaccine Adjuvants Type and Applications
    2.9.2.1 Type
    2.9.2.2 Type
  2.9.3 Aphios Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.9.4 Business Overview
  2.9.5 Aphios News
2.10 GSK
  2.10.1 Profile
  2.10.2 Vaccine Adjuvants Type and Applications
    2.10.2.1 Type
    2.10.2.2 Type
  2.10.3 GSK Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.10.4 Business Overview
  2.10.5 GSK News
2.11 CSL Limited
  2.11.1 Profile
  2.11.2 Vaccine Adjuvants Type and Applications
    2.11.2.1 Type
    2.11.2.2 Type
  2.11.3 CSL Limited Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.11.4 Business Overview
  2.11.5 CSL Limited News
2.12 Brenntag Biosector
  2.12.1 Profile
  2.12.2 Vaccine Adjuvants Type and Applications
    2.12.2.1 Type
    2.12.2.2 Type
  2.12.3 Brenntag Biosector Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.12.4 Business Overview
  2.12.5 Brenntag Biosector News
2.13 SEPPIC
  2.13.1 Profile
  2.13.2 Vaccine Adjuvants Type and Applications
    2.13.2.1 Type
    2.13.2.2 Type
  2.13.3 SEPPIC Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.13.4 Business Overview
  2.13.5 SEPPIC News
2.14 SPI Pharma
  2.14.1 Profile
  2.14.2 Vaccine Adjuvants Type and Applications
    2.14.2.1 Type
    2.14.2.2 Type
  2.14.3 SPI Pharma Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.14.4 Business Overview
  2.14.5 SPI Pharma News
2.15 Novavax
  2.15.1 Profile
  2.15.2 Vaccine Adjuvants Type and Applications
    2.15.2.1 Type
.2.2 Type
  2.15.3 Novavax Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.15.4 Business Overview
  2.15.5 Novavax News
2.16 Avanti Polar Lipids
  2.16.1 Profile
  2.16.2 Vaccine Adjuvants Type and Applications
    2.16.2.1 Type
    2.16.2.2 Type
  2.16.3 Avanti Polar Lipids Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.16.4 Business Overview
  2.16.5 Avanti Polar Lipids News
2.17 Aphios
  2.17.1 Profile
  2.17.2 Vaccine Adjuvants Type and Applications
    2.17.2.1 Type
    2.17.2.2 Type
  2.17.3 Aphios Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.17.4 Business Overview
  2.17.5 Aphios News

3 EUROPE VACCINE ADJUVANTS MARKET COMPETITION, BY MANUFACTURER

3.1 Europe Vaccine Adjuvants Sales and Market Share by Manufacturer (2016-2017)
3.2 Europe Vaccine Adjuvants Revenue and Market Share by Manufacturer (2016-2017)
3.3 Europe Vaccine Adjuvants Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Vaccine Adjuvants Manufacturer Market Share
  3.4.2 Top 5 Vaccine Adjuvants Manufacturer Market Share
3.5 Market Competition Trend

4 EUROPE VACCINE ADJUVANTS MARKET ANALYSIS BY COUNTRIES (2012-2017)

4.1 Europe Vaccine Adjuvants Sales Market Share by Countries (2012-2017)
4.2 Europe Vaccine Adjuvants Sales by Countries (2012-2017)
4.3 Europe Vaccine Adjuvants Revenue (Value) by Countries (2012-2017)

5 EUROPE MARKET SEGMENTATION VACCINE ADJUVANTS BY TYPE

5.1 Europe Vaccine Adjuvants Sales, Revenue and Market Share by Type (2012-2017)
  5.1.1 Europe Vaccine Adjuvants Sales and Market Share by Type (2012-2017)
  5.1.2 Europe Vaccine Adjuvants Revenue and Market Share by Type (2012-2017)
5.2 Oral Sales Growth and Price
  5.2.1 Europe Oral Sales Growth (2012-2017)
  5.2.2 Europe Oral Price (2012-2017)
5.3 Subcutaneous Sales Growth and Price
  5.3.1 Europe Subcutaneous Sales Growth (2012-2017)
  5.3.2 Europe Subcutaneous Price (2012-2017)
5.4 Intramuscular Sales Growth and Price
  5.4.1 Europe Intramuscular Sales Growth (2012-2017)
  5.4.2 Europe Intramuscular Price (2012-2017)
5.5 Others Sales Growth and Price
  5.5.1 Europe Others Sales Growth (2012-2017)
  5.5.2 Europe Others Price (2012-2017)

6 EUROPE MARKET SEGMENTATION VACCINE ADJUVANTS BY APPLICATION

6.1 Europe Vaccine Adjuvants Sales Market Share by Application (2012-2017)
6.2 Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications) Sales Growth (2012-2017)
6.3 Human Vaccine Adjuvants (Research Applications, Commercial Applications) Sales Growth (2012-2017)

7 GERMANY VACCINE ADJUVANTS SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

7.1 Germany Vaccine Adjuvants Revenue, Sales and Growth Rate (2012-2017)
7.2 Germany Vaccine Adjuvants Sales and Market Share by Type (2012-2017)
7.3 Germany Vaccine Adjuvants Sales by Application (2012-2017)
7.4 Germany Vaccine Adjuvants Sales, Revenue and Market Share by Manufacturer (2016-2017)
  7.4.1 Germany Vaccine Adjuvants Sales and Market Share by Manufacturer (2016-2017)
  7.4.2 Germany Vaccine Adjuvants Revenue and Market Share by Manufacturer
7.5 Germany Vaccine Adjuvants Export and Import (2012-2017)

8 UK VACCINE ADJUVANTS SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

8.1 UK Vaccine Adjuvants Revenue, Sales and Growth Rate (2012-2017)
8.2 UK Vaccine Adjuvants Sales and Market Share by Type (2012-2017)
8.3 UK Vaccine Adjuvants Sales by Application (2012-2017)
8.4 UK Vaccine Adjuvants Sales, Revenue and Market Share by Manufacturer (2016-2017)
  8.4.1 UK Vaccine Adjuvants Sales and Market Share by Manufacturer
  8.4.2 UK Vaccine Adjuvants Revenue and Market Share by Manufacturer
8.5 UK Vaccine Adjuvants Export and Import (2012-2017)

9 FRANCE VACCINE ADJUVANTS SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

9.1 France Vaccine Adjuvants Revenue, Sales and Growth Rate (2012-2017)
9.2 France Vaccine Adjuvants Sales and Market Share by Type (2012-2017)
9.3 France Vaccine Adjuvants Sales by Application (2012-2017)
9.4 France Vaccine Adjuvants Sales, Revenue and Market Share by Manufacturer (2016-2017)
  9.4.1 France Vaccine Adjuvants Sales and Market Share by Manufacturer
  9.4.2 France Vaccine Adjuvants Revenue and Market Share by Manufacturer
9.5 France Vaccine Adjuvants Export and Import (2012-2017)

10 RUSSIA VACCINE ADJUVANTS SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

10.1 Russia Vaccine Adjuvants Revenue, Sales and Growth Rate (2012-2017)
10.2 Russia Vaccine Adjuvants Sales and Market Share by Type
10.3 Russia Vaccine Adjuvants Sales by Application (2012-2017)
10.4 Russia Vaccine Adjuvants Sales, Revenue and Market Share by Manufacturer (2016-2017)
  10.4.1 Russia Vaccine Adjuvants Sales and Market Share by Manufacturer
  10.4.2 Russia Vaccine Adjuvants Revenue and Market Share by Manufacturer
10.5 Russia Vaccine Adjuvants Export and Import (2012-2017)

11 ITALY VACCINE ADJUVANTS SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

11.1 Italy Vaccine Adjuvants Revenue, Sales and Growth Rate (2012-2017)
11.2 Italy Vaccine Adjuvants Sales and Market Share by Type
11.3 Italy Vaccine Adjuvants Sales by Application (2012-2017)
11.4 Italy Vaccine Adjuvants Sales, Revenue and Market Share by Manufacturer (2016-2017)
  11.4.1 Italy Vaccine Adjuvants Sales and Market Share by Manufacturer
  11.4.2 Italy Vaccine Adjuvants Revenue and Market Share by Manufacturer
11.5 Italy Vaccine Adjuvants Export and Import (2012-2017)

12 VACCINE ADJUVANTS MARKET FORECAST (2017-2022)

12.1 Europe Vaccine Adjuvants Sales, Revenue and Growth Rate (2017-2022)
12.2 Vaccine Adjuvants Market Forecast by Countries (2017-2022)
  12.2.1 Germany Vaccine Adjuvants Sales Forecast (2017-2022)
  12.2.2 UK Vaccine Adjuvants Sales Forecast (2017-2022)
  12.2.3 France Vaccine Adjuvants Sales Forecast (2017-2022)
  12.2.4 Russia Vaccine Adjuvants Sales Forecast (2017-2022)
  12.2.5 Italy Vaccine Adjuvants Sales Forecast (2017-2022)
12.3 Vaccine Adjuvants Market Forecast by Type (2017-2022)
12.4 Vaccine Adjuvants Market Forecast by Application (2017-2022)

13 VACCINE ADJUVANTS MANUFACTURING COST ANALYSIS

13.1 Vaccine Adjuvants Key Raw Materials Analysis
  13.1.1 Key Raw Materials
  13.1.2 Price Trend of Key Raw Materials
  13.1.3 Key Suppliers of Raw Materials
  13.1.4 Market Concentration Rate of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
  13.2.1 Raw Materials
  13.2.2 Labor Cost
  13.2.3 Manufacturing Expenses
13.3 Manufacturing Process Analysis of Vaccine Adjuvants

14 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

14.1 Vaccine Adjuvants Industrial Chain Analysis
14.2 Upstream Raw Materials Sourcing
14.3 Raw Materials Sources of Vaccine Adjuvants Major Manufacturers in 2015
14.4 Downstream Buyers

15 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

15.1 Sales Channel
  15.1.1 Direct Marketing
  15.1.2 Indirect Marketing
  15.1.3 Marketing Channel Future Trend
15.2 Distributors, Traders and Dealers

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology
17.2 Analyst Introduction
17.3 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Vaccine Adjuvants Picture
Table Product Specifications of Vaccine Adjuvants
Figure Europe Sales Market Share of Vaccine Adjuvants by Types in 2016
Table Types of Vaccine Adjuvants
Figure Oral Picture
Table Major Manufacturers of Oral
Figure Subcutaneous Picture
Table Major Manufacturers of Subcutaneous
Figure Intramuscular Picture
Table Major Manufacturers of Intramuscular
Figure Others Picture
Table Major Manufacturers of Others
Table Europe Vaccine Adjuvants Sales Market Share by Applications in 2016
Table Applications of Vaccine Adjuvants
Figure Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications) Picture
Figure Human Vaccine Adjuvants (Research Applications, Commercial Applications) Picture
Figure Germany Vaccine Adjuvants Revenue (Million USD) and Growth Rate (2012-2022)
Figure France Vaccine Adjuvants Revenue (Million USD) and Growth Rate (2012-2022)
Figure UK Vaccine Adjuvants Revenue (Million USD) and Growth Rate (2012-2022)
Figure Russia Vaccine Adjuvants Revenue (Million USD) and Growth Rate (2012-2022)
Figure Italy Vaccine Adjuvants Revenue (Million USD) and Growth Rate (2012-2022)
Table SEPPIC Basic Information, Manufacturing Base and Competitors
Table SEPPIC Vaccine Adjuvants Type and Applications
Table SEPPIC Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table SDA BIO Basic Information, Manufacturing Base and Competitors
Table SDA BIO Vaccine Adjuvants Type and Applications
Table SDA BIO Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Brenntag Biosector Basic Information, Manufacturing Base and Competitors
Table Brenntag Biosector Vaccine Adjuvants Type and Applications
Table Brenntag Biosector Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table SPI Pharma Basic Information, Manufacturing Base and Competitors
Table SPI Pharma Vaccine Adjuvants Type and Applications
Table SPI Pharma Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table MVP Laboratories Basic Information, Manufacturing Base and Competitors
Table MVP Laboratories Vaccine Adjuvants Type and Applications
Table MVP Laboratories Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Tj Kaiwei Basic Information, Manufacturing Base and Competitors
Table Tj Kaiwei Vaccine Adjuvants Type and Applications
Table Tj Kaiwei Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novavax Basic Information, Manufacturing Base and Competitors
Table Novavax Vaccine Adjuvants Type and Applications
Table Novavax Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Zhuoyue Basic Information, Manufacturing Base and Competitors
Table Zhuoyue Vaccine Adjuvants Type and Applications
Table Zhuoyue Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Aphios Basic Information, Manufacturing Base and Competitors
Table Aphios Vaccine Adjuvants Type and Applications
Table Aphios Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table GSK Basic Information, Manufacturing Base and Competitors
Table GSK Vaccine Adjuvants Type and Applications
Table GSK Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table CSL Limited Basic Information, Manufacturing Base and Competitors
Table CSL Limited Vaccine Adjuvants Type and Applications
Table CSL Limited Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Brenntag Biosector Basic Information, Manufacturing Base and Competitors
Table Brenntag Biosector Vaccine Adjuvants Type and Applications
Table Brenntag Biosector Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table SEPPIC Basic Information, Manufacturing Base and Competitors
Table SEPPIC Vaccine Adjuvants Type and Applications
Table SEPPIC Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table SPI Pharma Basic Information, Manufacturing Base and Competitors
Table SPI Pharma Vaccine Adjuvants Type and Applications
Table SPI Pharma Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novavax Basic Information, Manufacturing Base and Competitors
Table Novavax Vaccine Adjuvants Type and Applications
Table Novavax Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Avanti Polar Lipids Basic Information, Manufacturing Base and Competitors
Table Avanti Polar Lipids Vaccine Adjuvants Type and Applications
Table Avanti Polar Lipids Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Aphios Basic Information, Manufacturing Base and Competitors
Table Aphios Vaccine Adjuvants Type and Applications
Table Aphios Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Europe Vaccine Adjuvants Sales by Manufacturer (2016-2017)
Figure Europe Vaccine Adjuvants Sales Market Share by Manufacturer in 2016
Figure Europe Vaccine Adjuvants Sales Market Share by Manufacturer in 2017
Table Europe Vaccine Adjuvants Revenue by Manufacturer (2016-2017)
Figure Europe Vaccine Adjuvants Revenue Market Share by Manufacturer in 2016
Figure Europe Vaccine Adjuvants Revenue Market Share by Manufacturer in 2017
Table Europe Vaccine Adjuvants Price by Manufacturers (2016-2017)
Figure Top 3 Vaccine Adjuvants Manufacturer Market Share in 2015
Figure Top 3 Vaccine Adjuvants Manufacturer Market Share in 2016
Figure Top 5 Vaccine Adjuvants Manufacturer Market Share in 2015
Figure Top 5 Vaccine Adjuvants Manufacturer Market Share in 2016
Figure Europe Vaccine Adjuvants Sales and Growth (2012-2017)
Table Europe Vaccine Adjuvants Sales by Countries (2012-2017)
Table Europe Vaccine Adjuvants Sales Market Share by Countries (2012-2017)
Figure Europe 2012 Vaccine Adjuvants Sales Market Share by Countries
Figure Europe 2016 Vaccine Adjuvants Sales Market Share by Countries
Figure Europe Vaccine Adjuvants Revenue and Growth (2012-2017)
Table Europe Vaccine Adjuvants Revenue by Countries (2012-2017)
Table Europe Vaccine Adjuvants Revenue Market Share by Countries (2012-2017)
Table Europe 2012 Vaccine Adjuvants Revenue Market Share by Countries
Table Europe 2016 Vaccine Adjuvants Revenue Market Share by Countries
Table Europe Vaccine Adjuvants Sales by Type (2012-2017)
Table Europe Vaccine Adjuvants Sales Share by Type (2012-2017)
Table Europe Vaccine Adjuvants Revenue by Type (2012-2017)
Table Europe Vaccine Adjuvants Revenue Share by Type (2012-2017)
Figure Europe Oral Sales Growth (2012-2017)
Figure Europe Oral Price (2012-2017)
Figure Europe Subcutaneous Sales Growth (2012-2017)
Figure Europe Subcutaneous Price (2012-2017)
Figure Europe Intramuscular Sales Growth (2012-2017)
Figure Europe Intramuscular Price (2012-2017)
Figure Europe Others Sales Growth (2012-2017)
Figure Europe Others Price (2012-2017)
Table Europe Vaccine Adjuvants Sales by Application (2012-2017)
Table Europe Vaccine Adjuvants Sales Share by Application (2012-2017)
Figure Europe Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications) Sales Growth (2012-2017)
Figure Europe Human Vaccine Adjuvants (Research Applications, Commercial Applications) Sales Growth (2012-2017)
Figure Germany Vaccine Adjuvants Revenue and Growth (2012-2017)
Figure Germany Vaccine Adjuvants Sales and Growth (2012-2017)
Table Germany Vaccine Adjuvants Sales by Type (2012-2017)
Table Germany Vaccine Adjuvants Sales Market Share by Type (2012-2017)
Table Germany Vaccine Adjuvants Sales by Application (2012-2017)
Table Germany Vaccine Adjuvants Sales Market Share by Application (2012-2017)
Table Germany Vaccine Adjuvants Sales by Manufacturer (2016-2017)
Figure Germany Vaccine Adjuvants Sales Market Share by Manufacturer in 2016
Figure Germany Vaccine Adjuvants Sales Market Share by Manufacturer in 2017
Table Germany Vaccine Adjuvants Revenue by Manufacturer (2016-2017)
Figure Germany Vaccine Adjuvants Revenue Market Share by Manufacturer in 2016
Figure Germany Vaccine Adjuvants Revenue Market Share by Manufacturer in 2017
Table Germany Vaccine Adjuvants Export and Import (2012-2017)
Figure UK Vaccine Adjuvants Revenue and Growth (2012-2017)
Figure UK Vaccine Adjuvants Sales and Growth (2012-2017)
Table UK Vaccine Adjuvants Sales by Type (2012-2017)
Table UK Vaccine Adjuvants Sales Market Share by Type (2012-2017)
Table UK Vaccine Adjuvants Sales by Application (2012-2017)
Table UK Vaccine Adjuvants Sales Market Share by Application (2012-2017)
Table UK Vaccine Adjuvants Sales by Manufacturer (2016-2017)
Figure UK Vaccine Adjuvants Sales Market Share by Manufacturer in 2016
Figure UK Vaccine Adjuvants Sales Market Share by Manufacturer in 2017
Table UK Vaccine Adjuvants Revenue by Manufacturer (2016-2017)
Figure UK Vaccine Adjuvants Revenue Market Share by Manufacturer in 2016
Figure UK Vaccine Adjuvants Revenue Market Share by Manufacturer in 2017
Table UK Vaccine Adjuvants Export and Import (2012-2017)
Figure France Vaccine Adjuvants Revenue and Growth (2012-2017)
Figure France Vaccine Adjuvants Sales and Growth (2012-2017)
Table France Vaccine Adjuvants Sales by Type (2012-2017)
Table France Vaccine Adjuvants Sales Market Share by Type (2012-2017)
Table France Vaccine Adjuvants Sales by Application (2012-2017)
Table France Vaccine Adjuvants Sales Market Share by Application (2012-2017)
Table France Vaccine Adjuvants Sales by Manufacturer (2016-2017)
Figure France Vaccine Adjuvants Sales Market Share by Manufacturer in 2016
Figure France Vaccine Adjuvants Sales Market Share by Manufacturer in 2017
Table France Vaccine Adjuvants Revenue by Manufacturer (2016-2017)
Figure France Vaccine Adjuvants Revenue Market Share by Manufacturer in 2016
Figure France Vaccine Adjuvants Revenue Market Share by Manufacturer in 2017
Table France Vaccine Adjuvants Export and Import (2012-2017)
Figure Russia Vaccine Adjuvants Revenue and Growth (2012-2017)
Figure Russia Vaccine Adjuvants Sales and Growth (2012-2017)
Table Russia Vaccine Adjuvants Sales by Type (2012-2017)
Table Russia Vaccine Adjuvants Sales Market Share by Type (2012-2017)
Table Russia Vaccine Adjuvants Sales by Application (2012-2017)
Table Russia Vaccine Adjuvants Sales Market Share by Application (2012-2017)
Table Russia Vaccine Adjuvants Sales by Manufacturer (2016-2017)
Figure Russia Vaccine Adjuvants Sales Market Share by Manufacturer in 2016
Figure Russia Vaccine Adjuvants Sales Market Share by Manufacturer in 2017
Table Russia Vaccine Adjuvants Revenue by Manufacturer (2016-2017)
Figure Russia Vaccine Adjuvants Revenue Market Share by Manufacturer in 2016
Figure Russia Vaccine Adjuvants Revenue Market Share by Manufacturer in 2017
Table Russia Vaccine Adjuvants Export and Import (2012-2017)
Figure Italy Vaccine Adjuvants Revenue and Growth (2012-2017)
Figure Italy Vaccine Adjuvants Sales and Growth (2012-2017)
Table Italy Vaccine Adjuvants Sales by Type (2012-2017)
Table Italy Vaccine Adjuvants Sales Market Share by Type (2012-2017)
Table Italy Vaccine Adjuvants Sales by Application (2012-2017)
Table Italy Vaccine Adjuvants Sales Market Share by Application (2012-2017)
Table Italy Vaccine Adjuvants Sales by Manufacturer (2016-2017)
Figure Italy Vaccine Adjuvants Sales Market Share by Manufacturer in 2016
Figure Italy Vaccine Adjuvants Sales Market Share by Manufacturer in 2017
Table Italy Vaccine Adjuvants Revenue by Manufacturer (2016-2017)
Figure Italy Vaccine Adjuvants Revenue Market Share by Manufacturer in 2015
Figure Italy Vaccine Adjuvants Revenue Market Share by Manufacturer in 2016
Table Italy Vaccine Adjuvants Export and Import (2012-2017)
Figure Europe Vaccine Adjuvants Sales, Revenue and Growth Rate (2017 -2022)
Table Europe Vaccine Adjuvants Sales Forecast by Countries (2017-2022)
Table Europe Vaccine Adjuvants Market Share Forecast by Countries (2017-2022)
Figure Germany Vaccine Adjuvants Sales Forecast (2017-2022)
Figure UK Vaccine Adjuvants Sales Forecast (2017-2022)
Figure France Vaccine Adjuvants Sales Forecast (2017-2022)
Figure Russia Vaccine Adjuvants Sales Forecast (2017-2022)
Figure Italy Vaccine Adjuvants Sales Forecast (2017-2022)
Table Europe Vaccine Adjuvants Sales Forecast by Type (2017-2022)
Table Europe Vaccine Adjuvants Market Share Forecast by Type (2017-2022)
Table Europe Vaccine Adjuvants Sales Forecast by Application (2017-2022)
Table Europe Vaccine Adjuvants Market Share Forecast by Application (2017-2022)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Vaccine Adjuvants
Figure Manufacturing Process Analysis of Vaccine Adjuvants
Figure Vaccine Adjuvants Industrial Chain Analysis
Table Raw Materials Sources of Vaccine Adjuvants Major Manufacturers in 2015
Table Major Buyers of Vaccine Adjuvants
Table Distributors/Traders/ Dealers List